🟪 Elephant Signal

🟪 Elephant Signal

Home
Notes
Archive
About
Round 1! Mike Tyson fights for cannabis with Trump
The former boxing star leads a celebrity coalition fight with the U.S. government for cannabis reforms, while Beckley Psytech’s BPL-003 and high-dose…
Why a Psilocybin-Melatonin Hybrid Could Be the Next Big Step in Mental Health Treatment
By the Pink Elephant Editorial Team
Veterans are getting psilocybin while cannabis laws keep bouncing back and forth
Federal support for MDMA and psilocybin therapy marks a new chapter in drug policy, as THC Therapeutics acquires cannabis operations in an $11 million…
Big bets on psychedelics: $10 million from Australia and $100 million from Texas
Australia’s largest private health insurer will fund MDMA-assisted therapy, while Texas commits $100 million to advance psychedelic research
 • 
Alexey Almazov
Novel LSD-related fungus and the aging cannabis market
A week defined by scientific advances, evolving markets, regulatory changes, and a complex public narrative shaped by policy progress and high-profile…
 • 
blackbox
May the Spores Be With You: Psychedelics Navigate a Gauntlet of Change and Opportunity
Product innovation, Big Pharma’s entry, and Europe’s progressive approach shape the cannabis and psychedelics markets, while social advocacy and…
 • 
blackbox
Guess Who Supports Psychedelics — Priests or the FDA?
FDA rejection of MDMA therapy contrasts with rising social advocacy and international progress, highlighting an accelerating yet complex path for…
 • 
blackbox
From Healing to Hustle: The Age of Psychedelic Capitalism and Paid Trip Sitters
With mushroom sales projected to hit $3.3 billion by 2031 and paid trip sitting on the rise, the psychedelic space is evolving fast, raising new…
 • 
blackbox
Portugal Approves Psychedelic Therapy, Christian Angermayer Supports atai
Public funding in Europe and major biotech reinvestment signal a growing shift toward psychedelic legitimacy, while cannabis markets expose the pitfalls…
 • 
blackbox
April 2025: Psychedelics Surge Towards Mainstream Medicine as Cannabis Navigates a Perfect Storm
Psilocybin therapy gains legal ground in several U.S. states and sees progress in key clinical trials, while cannabis markets contend with financial…
 • 
blackbox
THC Connoisseurs and Psilocin Analog Signal Next Phase for Psychedelics
Experience-driven audiences, Cybin’s psilocin analog patent, and emerging legislation point to a shifting landscape where innovation, regulation, and…
 • 
blackbox
Legal Psilocybin Therapy Arrives: Colorado Opens Doors, Eyes Now on the FDA
State-level reform picks up speed with Colorado’s first healing center and new bills in California and Connecticut, while U.S. federal agencies signal…
 • 
blackbox
🟪 Elephant Signal
🟪 Elephant Signal
A weekly digest of psychedelics space 🟪 breakthrough science, business deals, policy shifts, social change, comments from industry experts — all in one place

🟪 Elephant Signal

AboutArchive
© 2025 blackbox
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture